Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention.
Dongyoung LeeJe Sang KimBeom Jin KimSeung Yong ShinDong Bin KimHyeong Sik AhnPublished in: Medicine (2022)
The post-PCI patients on dual antiplatelet therapy with clopidogrel in the PPI group were associated with higher risk of MACE and MI. Although the results for rabeprazole were not robust, it was the only PPI that did not yield a significantly increased risk of MACE.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- end stage renal disease
- newly diagnosed
- atrial fibrillation
- ejection fraction
- coronary artery bypass
- prognostic factors
- heart failure
- small molecule